Feedback / Questions
ALLO-316 - Allogene Overland Biopharm
cemacabtagene ansegedleucel (ALLO-501A) - Allogene Therap
https://www.globenewswire.com/news-release/2025/05/22/3087175/0/en/Allogene-Therapeutics-Announces-ASCO-2025-Abstract-Publication-Featuring-Oral-Presentation-of-ALLO-316-in-Kidney-Cancer-and-ALPHA3-TIP-Poster-for-Cema-Cel.html
May 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next